Please click “>” to begin the survey *Abbreviated Rules: NO PURCHASE NECESSARY. Void in Rhode Island and where prohibited by law. Subject to all applicable laws. Sweepstakes begins on or about November 17, 2020, at 12:01 a.m. ET and ends on March 2, 2021, at 11:59 p.m. ET. Open only to legal United States residents who are older than the age of majority in his or her state of residence at the…
Arun Jesudian, MD; Ralph J. Riello, PharmD, BCPS, and Chas McCormick, RPh, MBA, delve into the complexities of hepatic encephalopathy, exploring the various risk factors…
IMPACT CKD, a modeling analysis created by AstraZeneca, includes data about chronic kidney disease across 8 countries, including the United States.
Ustekinumab (Stelara; Janssen Immunology) is a human monoclonal antibody that treats immune-mediated diseases such as psoriasis and psoriatic arthritis.
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.
The latest FDA approval paves the way for expanded use of GLP-1 receptor agonists in patients without diabetes.
The study is the first of 5 studies co-published by AYR Wellness and LECOM and showcases improvements in physical, social, and mental well-being with minimal…
AI offers many benefits in health professions by efficiently handling time-consuming tasks crucial for patient care.
If approved, the test could provide more timely and accurate diagnosis, hopefully mitigating the impact of Alzheimer disease (AD) on individuals and the community.
There was no difference observed between adalimumab (Humira; AbbVie) and adalimumab-aacf (Idacio; Fresenius Kabi) for those who switched to the biosimilar.
